Biocodex (Brand Secnol) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Biocodex (Brand Secnol) General Information
Description
A nitroimidazole antimicrobial drug brand.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
- France
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
- France
Biocodex (Brand Secnol) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biocodex (Brand Secnol) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Biocodex (Brand Secnol) FAQs
-
Where is Biocodex (Brand Secnol) headquartered?
Biocodex (Brand Secnol) is headquartered in France.
-
What industry is Biocodex (Brand Secnol) in?
Biocodex (Brand Secnol)’s primary industry is Buildings and Property.
-
Is Biocodex (Brand Secnol) a private or public company?
Biocodex (Brand Secnol) is a Private company.
-
What is Biocodex (Brand Secnol)’s current revenue?
The current revenue for Biocodex (Brand Secnol) is .
-
Who are Biocodex (Brand Secnol)’s investors?
Biocodex has invested in Biocodex (Brand Secnol).
-
When was Biocodex (Brand Secnol) acquired?
Biocodex (Brand Secnol) was acquired on 01-Jan-2022.
-
Who acquired Biocodex (Brand Secnol)?
Biocodex (Brand Secnol) was acquired by Athena Pharmaceutiques.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process